14158 Results (Page 306 of 567)
All Market Research Reports
APAC Home Healthcare Market Analysis
APAC home healthcare market was valued at $76.15 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.2% from 2022-30 and will reach $153.98 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the ageing population. The market is segmented by component and product. Some key players in this market are BestCare 24 (AUS), Portea Medical (IND), Healthcare at HOME (IND), Doctor Mate (JPN), Medtronic Japan (JPN), and many others.
APAC HIV Drugs Market Analysis
This report presents a strategic analysis of the APAC HIV Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the APAC HIV Drugs Market, offering unmatched value, accuracy and expert insights.
Vietnam Oncology Clinical Trials Market Analysis
Vietnam's oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $98.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022-30. The market will be driven by the big and diversified patient population available for clinical trials and a well-established clinical trial regulatory structure. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca PLC, Novartis AG & Hau Giang Pharmaceutical Joint Stock Company.
Vietnam Digital Health Market Analysis
Vietnam's Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by government support and the increasing use of technology in healthcare. The market is segmented by solution, by deployment & by end-use. Some of the major players include Jio Health, eDoctor & Thuocsi.
US Neurology Clinical Trials Market Analysis
The US neurology clinical trials market is projected to grow from $2.20 Bn in 2022 to $2.89 Bn by 2030, registering a CAGR of 3.5% during the forecast period of 2022-30. The prevalence of neurological disorders in the US is on the rise, with an aging population and changing lifestyles being significant contributors. As a result, there is a growing need for effective treatments and therapies to manage and treat these conditions, leading to an increase in neurology clinical trials. The US neurology clinical trials market is expected to grow significantly in the coming years, driven by an increasing prevalence of neurological disorders, a growing aging population, and advancements in technology and treatments.
US Clinical Trials Support Service Market Analysis
The US clinical trials support services market is projected to grow from $8.76 Bn in 2022 to $13.24 Bn by 2030, registering a CAGR of 5.3% during the forecast period of 2022-30. The high burden of infectious and chronic diseases in emerging economies, pharmaceutical companies' high R&D spending, an increase in the number of contract research organizations, and the prevalence of diseases are the main drivers of the market's expansion. The major key players in the market are Charles River Labs, Covance, Syneos Health, etc.
US Advanced Therapy Medicinal Products (ATMPs) Market Analysis
The US Advanced Therapy Medicinal Products (ATMPs) market is projected to grow from $4.3 Bn in 2022 to $9.8 Bn by 2030, registering a CAGR of 11% during the forecast period of 2022-30. One of the key drivers of growth in the US ATMP market is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. These diseases often require long-term treatment, and ATMPs offer a promising new approach to treating them. Additionally, advances in gene editing technologies such as CRISPR/Cas9 have increased the potential for ATMPs to cure genetic disorders. Some of the major players are Novartis International AG, Gilead Sciences, Inc., Bluebird Bio, Inc., Spark Therapeutics, Inc., and Kite Pharma, Inc.
UK Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UK Lung Cancer Therapeutics Market will reach a value of $1245 Mn from $775 Mn in 2022, growing at a CAGR of 6.1% during 2022-30. The Lung Cancer Therapeutics Market in the UK is dominated by a few domestic pharmaceutical companies such as Scancell, Sareum Holdings, and AstraZeneca. The Lung Cancer Therapeutics Market in the UK is segmented into different types of cancer and different therapy types. Some of the major factors affecting the UK lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
UK Diabetes Therapeutics Market Analysis
The UK diabetes therapeutics market is expected to grow from $3.74 Bn in 2022 to $6.77 Bn in 2030 with a CAGR of 7.7% for the forecasted year 2022-30. The rising incidence of diabetes and the subsequent demand for new and innovative treatment options for diabetes in the UK is driving the growth of the market. The UK diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Tanner Pharma, Bracco, and AstraZeneca are the major players in the UK diabetes therapeutics market.
UK Diabetes Devices Market Analysis
The UK Diabetes Devices Market is expected to witness growth from $591 Mn in 2022 to $887 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-30. Diabetes is becoming more common in the UK, which is raising the demand for diabetes devices. Continuous glucose monitoring systems and flash glucose monitoring systems are two examples of non-invasive and slightly invasive diabetes devices that are in increasing demand in the UK. The market is segmented by type and by the end user. Some key players in this market include Magstim, Deltex Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
UK Dental Care Market Analysis
The UK dental care market size is at around $933 Mn in 2022 and is projected to reach $1,317 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. 18% of the population has experienced one or more of the following oral problems: trouble pronouncing words, difficulty eating, embarrassment, self-consciousness, or terrible hurting in the mouth and 23.4% of 5-year-old children in England had experienced of dental decay. The report by Insights10 is segmented by treatment type, age group, clinical setup and demography and provides in-depth market insights.
UK 3D Imaging Market Analysis
The UK 3D imaging market is projected to grow from $0.79 Bn in 2022 to $2.33 Bn by 2030, registering a CAGR of 14.5% during the forecast period of 2022-30. The market will be driven by technological advancements and government initiatives to promote the same. The market is segmented by product, application, end-user & by portability. Some of the major players include Philips Healthcare, GE Healthcare & Vision RT Ltd.
UAE Pharmaceutical Market Analysis
This report presents a strategic analysis of the UAE Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
UAE Connected Healthcare Market Analysis
The UAE-connected healthcare market is projected to grow from $331.8 Mn in 2022 to $2608.26 Mn by 2030, registering a CAGR of 29.4% during the forecast period of 2022-30. The main factors driving the growth would be a favourable regulatory environment, strong healthcare infrastructure, government support and growing demand for healthcare services. The market is segmented by type, function and application. Some of the major players include Healthigo, Etisalat Digital Healthcare, Vezeeta, Cisco Systems, IBM and Philips Healthcare.
Turkey Robotic Surgery Services Market Analysis
This report presents a strategic analysis of the Turkey Robotic Surgery Services Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Robotic Surgery Services Market, offering unmatched value, accuracy and expert insights.
Turkey Oncology Drugs Market Analysis
This report presents a strategic analysis of the Turkey Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Turkey Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
Thailand Sleep Disorders Market Analysis
This report presents a strategic analysis of the Thailand Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
Thailand Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Thailand Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Healthcare Reimbursement Market, offering unmatched value, accuracy and expert insights.
Thailand COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the Thailand COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Thailand Breast Cancer Therapeutics Market Analysis
Thailand's breast cancer therapeutics is expected to witness a rise in the market size from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the year 2022-30 due to market drivers like changing lifestyle choices ultimately leading to breast cancer and high mortality ratios associated with breast cancer in Thailand. The market is segmented by therapy, by cancer type, and by distribution channel. ON Tanakit, Pfizer, and Bayer AG are some of the key players in the Thailand breast cancer therapeutics market.
Thailand Biomaterials in Healthcare Market Analysis
Thailand Biomaterials Healthcare Market is expected to witness growth from $188 Mn in 2022 to $518 Mn in 2030 with a CAGR of 13.54% for the forecasted year 2022-30. Geriatric population and a rise in medical problems, there is a rising demand for biomaterials in Thailand. The market is segmented by type and by application. Some key players in this market include Biomed, Meticuly, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Thailand Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Thailand Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Acne Therapeutics Market, offering unmatched value, accuracy and expert insights.
Tanzania Coronary Stents Market Analysis
Tanzania's Coronary Stents Market is expected to witness growth from $5 Mn in 2022 to $7 Mn in 2030 with a CAGR of 5.65% for the forecasted year 2022-30. The Tanzanian government has been spending money to upgrade the nation's healthcare system, which includes building more hospitals and clinics. With increased access to medical institutions, especially those performing coronary stent treatments, this investment is likely to spur market expansion. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Switzerland Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Switzerland Dermatology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as STADA Arzneimittel, Actelion Pharmaceuticals, and Medartis. The market is driven by government regulations and improved health indicators in the country. The dermatology drug market in Switzerland is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Sweden Neurology Devices Market Analysis
Sweden's Neurology Devices Market size was valued at $45 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022-30 and will reach $xx Mn in 2030. The market for neurology devices in Sweden is expanding as a result of rising healthcare spending, population growth, ageing, and the rising demand for healthcare services are some of the variables that are responsible for this increase in spending. The market is segmented by product type and by the end user. Some key players in the market include Medtronic, Stryker, Abbott Laboratories, B. Braun Melsungen AG, Abbott Laboratories, Johnson and Johnson, and Jude Medical.
